These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4784037

  • 1. [Concentration in the blood and excretion of para-aminosalicylic acid and its metabolites after intake of BEPAS preparation].
    Savula MM.
    Probl Tuberk; 1973; 51(10):44-7. PubMed ID: 4784037
    [No Abstract] [Full Text] [Related]

  • 2. [Metabolism of PASA during administration of the preparation once and thrice daily].
    Savula MM.
    Probl Tuberk; 1967; 45(4):70-4. PubMed ID: 5606807
    [No Abstract] [Full Text] [Related]

  • 3. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM, Kiselova ES.
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract] [Full Text] [Related]

  • 4. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
    Savula MM.
    Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491
    [No Abstract] [Full Text] [Related]

  • 5. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S.
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract] [Full Text] [Related]

  • 6. [Para-aminosalicylic acid metabolism in the body. VII. Resorption and tolerance of calcium-PAS compound and early results of treatment of pulmonary tuberculosis].
    Owsiński J, Kamińska M, Ostrowska A, Rapf T.
    Gruzlica; 1972 Jul; 40(7):635-7. PubMed ID: 5053842
    [No Abstract] [Full Text] [Related]

  • 7. Disturbances in the thyroid function during the treatment with the para-aminosalicylic acid derivatives.
    Górowski T, Gasiorowski W.
    Pol Med J; 1968 Jul; 7(3):638-42. PubMed ID: 5669704
    [No Abstract] [Full Text] [Related]

  • 8. [The para-aminosalicylic acid (PAS) level of the venous blood in patients after the administration of various PAS preparations for pulmonary tuberculosis].
    Kreukniet J, Tasman A, Bangma PJ.
    Ned Tijdschr Geneeskd; 1965 Sep 18; 109(38):1760-1. PubMed ID: 5317952
    [No Abstract] [Full Text] [Related]

  • 9. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J.
    Scand J Respir Dis; 1969 Sep 18; 50(3):169-85. PubMed ID: 5195904
    [No Abstract] [Full Text] [Related]

  • 10. [The level of p-amino salicylic acid, streptomycin, thiosemicarbazone and ethionamide in blood and urine following local treatment of cavernostomy cavities].
    Kandt D, Flach W.
    Beitr Klin Erforsch Tuberk Lungenkr; 1968 Sep 18; 137(3):226-32. PubMed ID: 5712004
    [No Abstract] [Full Text] [Related]

  • 11. [Studies on the metabolism of para-aminosalicylic acid in the body. VI. Absorption, tolerance and therapeutic effect of Napashin in double gastro-enteric coating].
    Nikodemowicz E, Owsiñski M, Kamiñska M, Ostrowska A, Rapf T.
    Gruzlica; 1971 Nov 18; 39(11):1113-21. PubMed ID: 5137653
    [No Abstract] [Full Text] [Related]

  • 12. Patient cooperation in taking medicines. A study involving isoniazid and aminosalicylic acid.
    Maddock RK.
    JAMA; 1967 Jan 16; 199(3):169-72. PubMed ID: 6071169
    [No Abstract] [Full Text] [Related]

  • 13. [On a case of simple goiter in a tuberculous subject treated with para-aminosalicylic acid].
    De Sanctis G, Petreni R.
    Atti Accad Fisiocrit Siena Med Fis; 1968 Jan 16; 17(2):1433-8. PubMed ID: 5760383
    [No Abstract] [Full Text] [Related]

  • 14. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh, Bilyk MA.
    Vrach Delo; 1981 Feb 16; (2):77-8. PubMed ID: 7222619
    [No Abstract] [Full Text] [Related]

  • 15. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J, Blom van Assendelft PM, Mouton RP, Tasman A, Bangma PJ.
    Scand J Respir Dis; 1966 Feb 16; 47(4):236-43. PubMed ID: 5182291
    [No Abstract] [Full Text] [Related]

  • 16. [PASA metabolism and the functional state of the adrenal cortex during chemotherapy combined with prednisolone in patients with pulmonary tuberculosis].
    Litvin LM, Savula MM.
    Sov Med; 1970 Feb 16; 33(5):54-60. PubMed ID: 5432970
    [No Abstract] [Full Text] [Related]

  • 17. Bioavailability studies on p-aminosalicylic acid and its various salts in man. II. Comparison of parasal and pascorbic.
    Pentikainen P, Wan SH, Azarnoff DL.
    Am Rev Respir Dis; 1973 Dec 16; 108(6):1340-70. PubMed ID: 4751720
    [No Abstract] [Full Text] [Related]

  • 18. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.
    Rasmussen SN, Bondesen S, Hvidberg EF, Hansen SH, Binder V, Halskov S, Flachs H.
    Gastroenterology; 1982 Nov 16; 83(5):1062-70. PubMed ID: 7117789
    [Abstract] [Full Text] [Related]

  • 19. [Hypersensitivity reactions to antituberculous drugs in pulmonary tuberculosis].
    Dukalski J, Stański K.
    Gruzlica; 1969 Oct 16; 37(10):937-41. PubMed ID: 5366986
    [No Abstract] [Full Text] [Related]

  • 20. [Studies on the metabolism of para-aminosalicylic acid in the body. IV. Effect of sodium salt of para-animosalicylic acid administered orally in coated tablets soluble in the intestine on the bacteriostatic level and on drug tolerance].
    Hornung S, Nilodemowicz E, Owsiński J, Rapf T.
    Gruzlica; 1967 Jul 16; 35(7):657-64. PubMed ID: 4865322
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.